Identification of Multiple CYP19 Genes Encoding Different Cytochrome P450 Aromatase Isozymes in Brain and Ovary
0013-7227/98/$03.00/0
Endocrinology
Copyright © 1998 by The Endocrine Society
Vol. 139, No. 4
Printed in U.S.A.
Identification of Multiple CYP19 Genes Encoding
Different Cytochrome P450 Aromatase Isozymes in Brain
and Ovary*
ANNA TCHOUDAKOVA† AND GLORIA V. CALLARD
Department of Biology, Boston University, Boston, Massachusetts 02215
ABSTRACT
Evidence to date indicates that the gene encoding cytochrome P450
aromatase (P450arom) in humans is a single member of the CYPl9
family, but multiple CYPl9 loci and isoforms have been identified in
pigs. Here we report the cloning and characterization of a second
member of the CYP19 family in goldfish. A search for P450arom
variants was prompted by studies showing that a full-length
P450arom complementary DNA (cDNA) isolated from a goldfish brain
cDNA library hybridizes with a high abundance 3 kb transcript in
brain RNA but fails to detect a message in ovarian RNA. A stepwise
PCR cloning strategy led to isolation of a 1.9-kb cDNA, which encodes
a protein of 518 amino acids and has a predicted mol wt of 58.7K. The
ovary-derived P450arom (-A) shares 68 –72% sequence identity with
ovarian aromatases of other fish species, but only 62% identity with
the homologous brain-derived P450arom (-B). Amino acid differences
are distributed throughout the two goldfish P450arom forms, but
presumptive functional domains are highly conserved. Both
I
N BOTH males and females, estrogen programs and coordinates developmental, physiological, and behavioral
responses essential for reproduction. Conversion of C19 androgens to C18 estrogens is the rate-limiting step in estrogen
biosynthesis and is catalyzed by an aromatase enzyme complex comprising a nicotinamide adenine dinucleotide phosphate (NADPH)-dependent cytochrome P450 reductase and
a cytochrome P450 aromatase (P450arom), a product of the
CYPl9 gene (for review, see Ref. 1). Although early studies
focused on estrogen biosynthesis in placenta and ovaries,
which are P450arom-rich and a major source of circulating
estrogen, it is now understood that smaller amounts of estrogen are formed in close proximity to estrogen receptors in
brain, fat, bone, gonads and other tissues, where it functions
as a paracrine or autocrine factor (1). Based primarily on
molecular cloning and characterization of P450arom complementary DNAs (cDNAs) from human tissues, the gene
encoding aromatase is thought to be a single member of the
CYP19 family, with regulatory complexity accomplished by
tissue-specific usage of multiple promoters and untranslated
first exons (1, 2).
Received October 7, 1997.
Address all correspondence and requests for reprints to: Gloria V.
Callard, Department of Biology, Boston University, 5 Cummington
Street, Boston, Massachusetts 02215. E-mail: .
* This work was supported by grants from the National Science
Foundation (IBN89 –16809 and IBN96 – 01297). The nucleotide sequence
reported in this paper has been submitted to the GenBank/EMBL Data
Bank with accession number AF020704.
† Recipient of an Endocrine Society Summer Fellowship.
P450aromA and -B are able to aromatize [3H]androgen to [3H]estrogen when expressed in nonsteroidogenic COS cells. Southern analysis
and PCR-restriction analysis of genomic DNA using discriminating
probes and primers indicates that a single locus encodes the brainderived P450aromB (CYPl9B), whereas one or two different loci encode the ovarian form (CYPl9A). Northern blot analysis revealed two
P450aromA messenger RNAs (1.9 .. 3.0 kb) in ovary. Simultaneous
PCR amplification with A- and B-specific primer pairs confirms that
P450aromA is the only form expressed in ovaries, but shows overlapping expression of the two genes in neural tissues. Whereas
P450aromB messenger RNA predominates in brain (B/A, '14:1), the
ratios are reversed in retina (B/A, '1:25). Further studies are required to resolve the evolutionary and functional implications of multiple CYPl9 genes and P450arom isozymes in goldfish, their differential expression in brain and ovary, and whether observations can
be generalized to other vertebrates. (Endocrinology 139: 2179 –2189,
1998)
The ability of the gonads and brain to aromatize androgen
is an evolutionarily conserved characteristic of vertebrates (3,
4). However, teleost fish, including the goldfish Carassius
auratus, are unique among vertebrates in having exceptionally high levels of brain aromatase activity: e.g. 100- to 1000fold higher than mammalian brain but similar to mammalian
ovary (5, 6). Enzyme activity is correspondingly high in teleost pituitary and retina, but ovarian aromatase is less than
one-tenth that of brain (6, 7). To address the molecular mechanism of high constitutive neural aromatase expression, a
full-length 3-kb P450arom cDNA was isolated from a goldfish brain library and used to show that high accumulated
levels of P450arom messenger RNA (mRNA) in brain correspond to high enzyme levels (8). Paradoxically, the brainderived cDNA failed to hybridize with ovarian mRNA under
any condition. This observation led us to postulate the existence of different brain and ovarian mRNA variants. Although evidence from chickens (9) and medaka fish (10)
supports studies in humans indicating that the CYPl9 gene
exists as a single copy in the haploid genome (11, 12), multiple CYPl9 loci encoding different P450arom isoforms in
placenta, ovary, and blastocysts were identified in pigs
(13–15).
Here we report the isolation of a second P450arom cDNA
from goldfish ovaries, and present evidence for multiple
CYPl9 gene loci encoding the brain- and ovarian-derived
P450arom forms. We show that both proteins are able to
catalyze estrogen production from radiolabeled androgen,
and are differentially expressed in neural and gonadal tis-
2179
2180
MULTIPLE CYPl9 GENES AND P450arom ISOZYMES
Endo • 1998
Vol 139 • No 4
sues. Preliminary findings have been reported elsewhere
(16).
Materials and Methods
Oligonucleotides
Oligonucleotides (Ransom Hill Bioscience, Ramona, CA) used as PCR
primers and probes for Southern analysis are listed below and shown
in Fig. 1. Primers 1–11 were used with the ovarian P450arom cDNA,
whereas 12–16 are complementary to brain P45Oarom cDNA:
Primer 1: nucleotides 1173–1197: 59 AGG TWC CAK CCN GTB GTS
GAC TTC 39 (IUB group codes were used: D 5 A1G1T; S 5 G1C; N 5
A1G1C1T; Y 5 C1T; R 5 A1G; K 5 G1T; B 5 G1T1C; V 5 G1A1C;
W 5 A1T).
Primer 2: nucleotides 1395–1416: 59 CACCATNGCDATRWRYTTNCC 39.
Primer 3: nucleotides 1316 –1337: 59 TGGAAGTTGTCTAGACTGAAC 39.
Primer 4: nucleotides 1303–1324: 59 GACTGAACTCATTCGGCTTGG
39.
Primer 5: nucleotides 338 –359: 59 RGTBTGGATCWVYGGAGARGA
39.
Primer 6: nucleotides 398 – 423: 59 TGAGGTGTACAGAGATTTCCTCAAC 39.
Primer 7: nucleotides 1301–1329: 59 CCCCAAGCCGAATGAGTTCAGTCTAGAC 39.
Primer 8: nucleotides 17– 43: 59 TCTTATGGCACGTGAACTTCTCCAGC 39.
Primer 9: nucleotides 1848 –1874: 59 CAGTAGAAGACACCAGTAATTCATAG 39.
Primer 10: nucleotides 1220 –1241: 59 TGATGTCATCGAAGGCTACAA 39.
Primer 11: nucleotides 1274 –129 (...truncated)